14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CCXI
Delisted

ChemoCentryx Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$51.99
+0 (+0%)
At Close: Jan 27, 2023
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $51.99 $51.99 Friday, 27th Jan 2023 CCXI stock ended at $51.99. During the day the stock fluctuated 0% from a day low at $51.99 to a day high of $51.99.
90 days $51.99 $51.99
52 weeks $14.95 $52.00

Historical ChemoCentryx prices

Date Open High Low Close Volume
Dec 22, 2021 $35.12 $36.70 $34.71 $36.53 798 063
Dec 21, 2021 $34.80 $35.52 $34.00 $35.16 1 381 375
Dec 20, 2021 $33.64 $35.44 $32.87 $34.58 1 418 146
Dec 17, 2021 $33.87 $35.94 $33.14 $34.38 6 686 608
Dec 16, 2021 $34.95 $35.17 $33.38 $33.94 1 169 778
Dec 15, 2021 $33.05 $34.89 $31.20 $34.75 1 969 455
Dec 14, 2021 $33.27 $33.89 $32.26 $33.17 1 294 483
Dec 13, 2021 $33.94 $35.11 $33.32 $33.96 1 126 240
Dec 10, 2021 $35.24 $35.79 $33.37 $33.54 1 007 924
Dec 09, 2021 $36.46 $37.11 $34.84 $35.02 1 012 346
Dec 08, 2021 $36.57 $36.83 $35.30 $36.60 1 315 662
Dec 07, 2021 $35.94 $37.22 $35.55 $36.15 1 132 904
Dec 06, 2021 $34.50 $35.43 $33.06 $35.03 1 080 666
Dec 03, 2021 $37.54 $37.54 $34.46 $34.66 1 225 792
Dec 02, 2021 $35.25 $37.80 $34.61 $37.06 1 480 563
Dec 01, 2021 $36.54 $38.95 $35.44 $35.48 2 293 404
Nov 30, 2021 $36.44 $37.38 $34.01 $36.28 1 901 485
Nov 29, 2021 $36.51 $37.60 $35.98 $36.90 1 299 002
Nov 26, 2021 $38.00 $38.95 $35.68 $36.28 1 247 169
Nov 24, 2021 $38.76 $39.55 $38.21 $38.88 737 788
Nov 23, 2021 $38.88 $39.40 $36.82 $39.19 1 065 143
Nov 22, 2021 $39.37 $41.83 $38.35 $38.68 2 230 834
Nov 19, 2021 $39.53 $40.95 $38.95 $39.60 1 369 870
Nov 18, 2021 $39.38 $39.84 $38.40 $39.47 1 108 058
Nov 17, 2021 $38.48 $39.84 $38.32 $39.52 1 484 158
Click to get the best stock tips daily for free!

About ChemoCentryx

ChemoCentryx ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of... CCXI Profile

Golden Star

Ticker Date Change Price
HRB Apr 29 1.00% $47.23
LYG Apr 29 0.391% $2.56
ORA Apr 29 1.95% $64.48
ETSY Apr 26 3.43% $67.43
DHT Apr 24 0.98% $11.28
LPLA Apr 19 1.10% $262.59
MLI Apr 19 7.29% $52.28
PFLT Apr 18 1.33% $11.25
DOOR Apr 18 0.94% $131.39
OCSL Apr 17 0.360% $19.43
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT